Stuff New Zealand Friday reported that Dunedin biotech firm Pacific Edge is seeking to raise $21 million from new and existing shareholders to fund a rollout out its flagship Cxbladder product overseas, in the United States.
To roll out the product it will establish a laboratory, under US federal regulatory standards, in Pennsylvania. The laboratory under [...]

The potential investor in the takeover of Crafar dairy farming empire, UBNZ Funds Management, announced that it had bought a controlling stake of 19.9% in Genesis Research.
Genesis Research and Development Corp. is an Auckland based biotechnology firm for which it is reported that the May Wang’s company paid an estimated $446,278 for. According to the [...]

Genesis Research and Development Corp., an Auckland based biotechnology company reported it had found a viable New Zealand investor and may rethink its decision to move its operations overseas. The company’s CEO, Stephen Halls, said Tuesday that the company expects to conclude the placement of 7.4 million shares at 6c per share, to raise $446, [...]

The Malaghan Institute of Medical Research will lead a $5 million research in therapeutic cancer vaccines. This investment into R&D by the Health Council of New Zealand (HRC) is expected to last for three to four years. It makes up for one of the main winners in an $81.88 million financing announced today by the [...]